Sentry Investments’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$277M Buy
4,450,500
+153,800
+4% +$11M 4.13% 1
2017
Q4
$312M Sell
4,296,700
-1,555,400
-27% -$113M 3.96% 1
2017
Q3
$476M Buy
5,852,100
+333,000
+6% +$26.3M 4.81% 2
2017
Q2
$444M Buy
5,519,100
+57,100
+1% +$4.51M 3.23% 4
2017
Q1
$429M Sell
5,462,000
-33,400
-0.6% -$2.67M 2.96% 4
2016
Q4
$434M Buy
5,495,400
+605,500
+12% +$49M 3.3% 4
2016
Q3
$435K Buy
4,889,900
+1,357,300
+38% +$128M 3.67% 4
2016
Q2
$338K Buy
3,532,600
+1,353,000
+62% +$135M 3.17% 5
2016
Q1
$226K Buy
2,179,600
+128,300
+6% +$12.5M 2.74% 6
2015
Q4
$201K Buy
2,051,300
+636,300
+45% +$62.3M 2.3% 7
2015
Q3
$137K Buy
1,415,000
+117,800
+9% +$12.4M 1.65% 14
2015
Q2
$136K Buy
1,297,200
+261,200
+25% +$26.7M 1.59% 14
2015
Q1
$107M Hold
1,036,000
1.35% 24
2014
Q4
$99.8M Sell
1,036,000
-62,800
-6% -$5.53M 1.25% 27
2014
Q3
$87.5M Buy
1,098,800
+64,000
+6% +$5.05M 1.1% 28
2014
Q2
$78M Buy
+1,034,800
New +$78.2M 0.97% 32

Other funds holding CVS

Sentry Investments's CVS Position: Q1 2018 in Review

Sentry Investments increased its CVS Health (CVS) stake by 3.6% in Q1 2018, buying an estimated $11M and bringing the position to 4,450,500 shares worth $277M. The position accounts for 4.13% of the portfolio, ranked #1.

Sentry Investments first reported a position in CVS in Q2 2014 and has held it in 16 quarters since. The position peaked at $476M in Q3 2017. 1,549 funds tracked by Wall St. Rank hold CVS as of Q1 2018.

  • Sentry Investments held 4,450,500 shares of CVS Health worth $277M as of Q1 2018.
  • Sentry Investments bought 153,800 CVS Health shares in Q1 2018, an estimated $11M.
  • CVS Health made up 4.13% of Sentry Investments's portfolio in Q1 2018, its #1 holding.
  • Sentry Investments first reported a position in CVS Health in Q2 2014 and has held it in 16 quarters since.
  • Sentry Investments's CVS Health position peaked at $476M in Q3 2017.
  • 1,549 funds tracked by Wall St. Rank held CVS Health as of Q1 2018.

Based on Sentry Investments's 13F filing for Q1 2018, filed 11 May 2018.